This website is for the U.S, for the other countries please refer to this link.
SUDOSCAN in Intradialytic hypotension Electrochemical skin conductance by SUDOSCAN: a new tool to predict intradialytic hypotension Pauline Reach, Maxime Touzot, Yannis Lombardi, Catherine Maheas, Emmanuelle
Screening diabetic neuropathy with SUDOSCAN in type 2 diabetes and prediabetes Juan J. Cabré, Teresa Mur, Bernardo Costa, Francisco Barrio, Charo López-Moya, Ramon Sagarra,
SUDOSCAN in autoimmune small fiber neuropathy Trevino, Jorge A. M.D., Novak, Peter MD. Ph.D. Article title: TS-HDS and FGFR3 Antibodies in Small Fiber Neuropathy and
SUDOSCAN in cardiovascular autonomic neuropathy screening Yun-Ru Lai, Chih-Cheng Huang, Ben-Chung Cheng, Nai-Wen Tsai, Wen-Chan Chiu, Hsueh-Wen Chang, Jung-Fu Chen, Cheng-Hsien Lu. Article title: Feasibility
Vitamin B12 Supplementation in Diabetic Neuropathy monitored with SUDOSCAN T. Didangelos et al. Article title: Vitamin B12 Supplementation in Diabetic Neuropathy: A 1-Year, Randomized, Double-Blind,
Sudomotor dysfunction in patients recovered from COVID-19 Anand Hinduja, Abdul Moutairou, Jean-Henri Calvet Article title: Sudomotor dysfunction in patients recovered from COVID-19. Neurophysiologie Clinique/Clinical Neurophysiology,
Promotional Communication. The medical devices SUDOSCAN is cleared by the US Food and Drug Administration (FDA). The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 2021/01/12